EJC Skin Cancer

Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study

Pub Date : 2026-01-01 DOI: 10.1016/j.ejcskn.2025.100773 Eva Ellebaek , Michael Weichenthal , Iva Gavrilova , Nethanel Asher , Patrick Terheyden , Jochen Utikal , Amina Jalovčić Suljeviić , Claudia Pföhler , Igor Stojkovski , Rudolf Alexander Herbst , Selma Ugurel , Christina Ruhlmann , Alfonso Berrocal , Margarita Majem , Branko Dujovic , Viktor Šabarić , Tomislav Duvancic , Ainara Soria , Marco Donia , Henrik Schmidt , Dirk Schadendorf

BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: A stratified, controlled, retrospective EUMelaReg multicenter study

Pub Date : 2026-01-01 DOI: 10.1016/j.ejcskn.2026.100776 Michael Weichenthal , Iva Gavrilova , Peter Mohr , Berna C. Özdemir , Nethanel Asher , Eva Ellebaek , Jens Ulrich , Alexander Kreuter , Aleksander Popovic , Christina Ruhlmann , Igor Stojkovski , Shaked Lev-Ari , Edgar Dippel , Almudena García Castaño , Lorena Bellido Hernández , Henrik Schmidt , Egle Ramelyte , Dimitrios Ziogas , Luisa Piccin , Katarzyna Kozak , Dirk Schadendorf

Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma

Pub Date : 2026-01-01 DOI: 10.1016/j.ejcskn.2026.100775 Adielle Abecassis , Laura Perray , Rafaele Molinier , Safa Idoudi , Helene Kemp , Céleste Lebbé , Laetitia Vercellino , Emilien Ezine , Marie Fournier